WAIT

MediJoint Pain is an all-natural joint pain treatment made exclusively from Platinum Grade Harpagophytum procumbens.

Native to the southern part of the African continent, this premium ingredient has been recognized throughout the ages for its pain-relieving, analgesic and anti-inflammatory properties.

More recently, a variety of studies have clearly demonstrated that MediJoint Pain:

  • Acts as a powerful analgesic

  • Reduces inflammation

  • Significantly improves mobility

Take a look at some of the results for yourself...

In a 12-week, open-label study involving 75 patients with arthrosis of the hip or knee, patients demonstrated:

  • A progressive improvement in mobility (2.03 at baseline vs. 1.32 at 12 weeks; a 35% improvement)

  • A progressive improvement in pain (1.45 at baseline vs. 0.79 at 12 weeks; a 46% improvement)

    (Wegener T and Lupke NP. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC. Phytotherapy Research 2003;17:1165-1172).

In a double-blind, randomized, placebo-controlled trial involving patients with osteoarthritis, patients demonstrated:

  • A significant reduction in pain vs. placebo at Day 30 (p=0.018) and at Day 60 (p=0.012)

In a separate double-blind, randomized, placebo-controlled trial involving patients with osteoarthritis of the hip, patients demonstrated:

  • A significant improvement in total WOMAC* and stiffness scores vs. placebo (p=0.039 and p=0.026 respectively)

    * WOMAC=Western Ontario and McMaster Universities Osteoarthritis Index

In a double-blind, randomized, active comparator trial:

  •  Harpagophytum procumbens was demonstrated to be at least as effective as diacerein (p=0.001) in reducing pain severity

    (Brien S et al. Devil's claw (Harpagophytum procumbens) as a treatment for osteoarthritis: A review of efficacy and safety. J Alternative and Complementary Medicine 2006;12(10)981-993).

What's more, MediJoint Pain is safe:

  • In a double-blind, randomized, active-comparator trial, 80% of patients taking Harpagophytum procumbens classified tolerability as "very good," "good" or "satisfying" vs. 72% of those taking conventional medication

    (Brien S et al. Devil's claw (Harpagophytum procumbens) as a treatment for osteoarthritis: A review of efficacy and safety. J Alternative and Complementary Medicine 2006;12(10)981-993).